FDA
-
-
-
-
-
-
-
Greenwich LifeSciences (GLSI) Provides Update on Open Label HLA Data from FLAMINGO-01
-
-
-
-
-
-
-
Greenwich LifeSciences Provides Year End Update
-
-
-
-
-
-
-
Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
-
-
-
-
-
-
-
Greenwich LifeSciences to Ring Nasdaq Opening Bell on December 28
-
-
-
-
-
-
-
Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

